Guizhou Yibai Pharmaceutical Co., Ltd. is a high-tech enterprise integrating the research, development, production and sales of new drugs. The company's predecessor was Guizhou Miaoling Pharmaceutical Co., Ltd., which was founded on June 12, 1995. It was renamed Guizhou Yibai Pharmaceutical Co., Ltd. the following year. After continuous development and growth over the years, with the strong support of the Guizhou Provincial People's Government, the company successfully completed the joint-stock reform on November 28, 2000, and officially became Guizhou Yibai Pharmaceutical Co., Ltd., and was established in Shanghai on March 8, 2004. Successfully listed on the stock exchange (stock code 600594), becoming the first non-public pharmaceutical company in Guizhou Province to obtain listing qualifications.
Guizhou Yibai Pharmaceutical Co., Ltd. (hereinafter referred to as the "Company or the Company") was approved by the Guizhou Provincial People's Government (Qianfu Han [2000] No. 785) in November 2000. The company was restructured as a whole, with a registered capital of 47 million yuan.
On March 1, 2004, as approved by the China Securities Regulatory Commission’s Zheng Jian Fa Zi [2004] No. 19 document, the company issued RMB ordinary shares to the public through placement on March 8, 2004 ( A shares) 20 million shares, officially listed on the Shanghai Stock Exchange on March 23. The cumulative registered capital after the issuance is RMB 67 million, which has been verified by the capital verification report No. [2004] 001 of Beijing Zhongzheng Guohua Accounting Firm Co., Ltd., and has been re-registered.
On May 20, 2005, the company's 2004 annual shareholders' meeting reviewed and approved the "Plan for the Company's 2004 Capital Reserves to be Converted into Share Capital". The cumulative registered capital after the conversion was RMB 80.40 million, which has been transferred to Beijing China Securities Guohua Accounting Firm Co., Ltd. Jingzhong Securities Beishen Sanyanzi [2005] No. 1030 Capital Verification Report has been verified and has been re-registered.
On May 13, 2006, the company's 2005 annual shareholders' meeting reviewed and approved the "Plan for the Company's 2005 Capital Reserves to be Converted into Share Capital". The cumulative registered capital after the conversion was RMB 120.60 million, which has been transferred to Beijing The capital verification report No. 1028 of CSI Guohua Accounting Co., Ltd. Jingzhong Securities Beishen Sanyanzi [2006] has been verified and has been re-registered.
On August 31, 2007, the company's second extraordinary shareholders' meeting in 2007 reviewed and approved the "Plan for the Company's 2006 Capital Reserve Conversion into Share Capital". The cumulative registered capital after the conversion was RMB 180.90 million. Yuan, has been verified by Beijing Zhongzheng Tiantong Accounting Firm Co., Ltd. Beijing Zhongzheng Tiantong Beishen Sanyanzi [2007] No. 1066 Capital Verification Report, and has been re-registered.
On May 27, 2008, the company's shareholders' meeting reviewed and approved the "Proposal for the Company's Profit Distribution in 2007". The cumulative registered capital after the transfer was RMB 235.17 million, and it has been certified by Beijing CSI Tiantong Accountants The Capital Verification Report No. 1078 of Jingzhong Securities Tiantong Beishen Sanyanzi (2008) of the Firm Co., Ltd. has been verified and has been re-registered.
On September 16, 2010, the company's second extraordinary shareholders' meeting in 2010 reviewed and approved the "Company's 2010 Interim Profit Distribution Plan". The cumulative registered capital after the increase was RMB 352.755 million. It has been verified by the Capital Verification Report No. 1208 of Beijing CSI Tiantong Accounting Firm Co., Ltd. CSI Tiantong [2010] and has been re-registered.
Securities information editing
Stock code 600594
Stock abbreviation Yibai Pharmaceutical
Code category A shares
Listing place Shanghai Stock Exchange
Old code 600594
Administrative division name--
Listing status change
Reason for change New listing< /p>
Change date 2004-03-23
Stock abbreviation change
Stock abbreviation Yibai Pharmaceutical
Change date 2006-10-09< /p>
Stock abbreviation G Yibai
Change date 2005-12-05
Industry changes
Enter the industry of Chinese medicinal materials and proprietary Chinese medicine processing industry
Date of change 2004-03-03
Entered the industry (no data)
Date of change 2004-03-18